Neumann, Anne
Schmitt, Jochen
Seifert, Martin
Kliemt, Roman
March, Stefanie
Häckl, Dennis
Swart, Enno
Pfennig, Andrea
Baum, Fabian
Funding for this research was provided by:
More than 70 German statutory health insurance funds
Technische Universität Dresden
Article History
Received: 23 February 2023
Accepted: 4 January 2024
First Online: 26 January 2024
Declarations
:
: Due to the retrospective nature of the study and the analysis of anonymous data, the ethics committee of the Otto-von-Guericke-University at the Medical Faculty and University Hospital Magdeburg confirmed that no ethical approval was necessary.
: Not applicable.
: The Technische Universität Dresden, the University of Magdeburg, and WIG2 received funding for this study. This funding did not have any influence on the design, methods, and evaluation of the study.Independent of this project, JS received institutional funding for scientifically-initiated research from the Federal Joint Committee (Gemeinsamer Bundesausschuss (GB-A)), the German Health Ministry (Bundesgesundheitsministerium (BMG)), Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung (BMBF)), Free State of Saxony, Novartis, Sanofi, ALK and Pfizer. He participated as a consultant in advisory board meetings of Sanofi, Lilly, and ALK and received a personal honorarium. JS is a member of the Expert Council on Health and Care at the Federal Ministry of Health (Sachverständigenrat Gesundheit und Pflege am Bundesministerium für Gesundheit) and a member of the Government Commission for Modern and Demand-oriented Hospital Care of the traffic light coalition (Regierungskommission für eine moderne und bedarfsgerechte Krankenhausversorgung der Ampelkoalition). All other authors declare that they have no conflicts of interest.